These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23786280)

  • 1. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
    Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
    Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor in allergen-induced nasal inflammation.
    Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
    Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients.
    Fuentes-Beltrán A; Montes-Vizuet R; Valencia-Maqueda E; Negrete-García MC; García-Cruz Mde L; Teran LM
    Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
    Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS
    Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease.
    Yoo HS; Shin YS; Liu JN; Kim MA; Park HS
    Int Arch Allergy Immunol; 2013; 162(4):340-5. PubMed ID: 24193355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
    Kowalski ML; Grzegorczyk J; Wojciechowska B; Poniatowska M
    Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
    Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between specific IgA and eosinophil numbers in the lavage fluid of patients with perennial allergic rhinitis.
    Oh JH; Hur GY; Ye YM; Kim JE; Park K; Park HS
    Allergy Asthma Proc; 2008; 29(2):152-60. PubMed ID: 18430312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum periostin with aspirin-exacerbated respiratory disease.
    Kim MA; Izuhara K; Ohta S; Ono J; Yoon MK; Ban GY; Yoo HS; Shin YS; Ye YM; Nahm DH; Park HS
    Ann Allergy Asthma Immunol; 2014 Sep; 113(3):314-20. PubMed ID: 25037608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
    Perić A; Gaćeša D; Cvetković G; Vojvodić D
    Immun Inflamm Dis; 2023 Feb; 11(2):e791. PubMed ID: 36840483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease.
    Palikhe NS; Kim SH; Cho BY; Ye YM; Choi GS; Park HS
    Allergy; 2010 Mar; 65(3):338-46. PubMed ID: 19796209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma apolipoprotein H levels are different between aspirin induced respiratory diseases and aspirin tolerant asthma.
    Kim HJ; Park JS; Heo JS; Moon KY; Park CS
    Pulm Pharmacol Ther; 2014 Apr; 27(2):184-9. PubMed ID: 24120690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal lavage fluid and proteomics as means to identify the effects of the irritating epoxy chemical dimethylbenzylamine.
    Lindahl M; Irander K; Tagesson C; Ståhlbom B
    Biomarkers; 2004; 9(1):56-70. PubMed ID: 15204311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].
    Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T; Kato A; Berdnikovs S; Stevens WW; Suh LA; Norton JE; Carter RG; Harris KE; Peters AT; Hulse KE; Grammer LC; Welch KC; Shintani-Smith S; Tan BK; Conley DB; Kern RC; Bochner BS; Schleimer RP
    J Allergy Clin Immunol; 2017 Sep; 140(3):720-729. PubMed ID: 28238741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.